Serum Chromogranin A (CgA)
49-kDa major acidic glycoprotein co-stored and co-released with peptide hormones and catecholamines from neuroendocrine secretory granules.
Standard vs. Optimal Reference Rangesng/mL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
<100.0 ng/mL
General reference distribution across unselected commercial populations.
<50.0 ng/mL
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Acts as the prohormone precursor for regulatory peptides (vasostatin, chromacin); serum levels correlate with total neuroendocrine tumor burden.
Differential Diagnosis
Elevated Levels (CgA High)
- •Neuroendocrine tumors (carcinoid tumors, insulinomas, gastrinomas)
- •Proton pump inhibitor (PPI) therapy (causes false-positive elevations)
- •Severe renal insufficiency
Low Levels (CgA Low)
- •Normal neuroendocrine quiescence
- •Post-PPI discontinuation true baseline
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for CgA
- Targeted organ system imaging or functional dynamic testing related to neuroendocrine secretory core protein
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Serum Chromogranin A - The New England Journal of Medicine (2021). PMID: 34090124
- [2]CgA Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35322901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Serum Chromogranin A (CgA) into overall healthspan optimization.